Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.62 |
| ▸ | TNKS | O95271 | 9/20 | 0.56 |
| ▸ | PARP1 | P09874 | 9/20 | 0.56 |
| ▸ | PARP2 | Q9UGN5 | 9/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14637530 | 0.88 | MAPT (0.55) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL22227916 | 0.83 | MAPT (0.53) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL22228020 | 0.83 | MAPT (0.48) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL440844 | 0.83 | SMN1; SMN2 (0.65) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL14638193 | 0.83 | TNKS (0.54) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL17339930 | 0.82 | POLB (0.55) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL462934 | 0.81 | ALDH1A1 (0.52) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL22227907 | 0.81 | MAPT (0.47) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL13666086 | 0.81 | RBP4 (0.55) | HDAC3CYP2C9HDAC1HDAC6TNKS | |
| SCHEMBL16400168 | 0.80 | LMNA (0.40) | HDAC3CYP2C9HDAC1HDAC6TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2731942-A1 | NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS | Novartis AG (CH) | 2014-05-21 | — | — | EP | disclosed |
| US-7217714-B1 | CCR5 modulators | AGOURON PHARMACEUTICALS, INC. (US) | 2007-05-15 | — | — | US | disclosed |